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The use of additives in food products has become an important public health concern. 
In recent reports, dietary emulsifiers have been shown to affect the gut microbiota, 
contributing to a pro-inflammatory phenotype and metabolic syndrome. So far, it is not 
yet known whether similar microbiome shifts are observable for a more diverse set of 
emulsifier types and to what extent these effects vary with the unique features of an 
individual’s microbiome. To bridge this gap, we  investigated the effect of five dietary 
emulsifiers on the fecal microbiota from 10 human individuals upon a 48 h exposure. 
Community structure was assessed with quantitative microbial profiling, functionality was 
evaluated by measuring fermentation metabolites, and pro-inflammatory properties were 
assessed with the phylogenetic prediction algorithm PICRUSt, together with a TLR5 
reporter cell assay for flagellin. A comparison was made between two mainstream chemical 
emulsifiers (carboxymethylcellulose and P80), a natural extract (soy lecithin), and 
biotechnological emulsifiers (sophorolipids and rhamnolipids). While fecal microbiota 
responded in a donor-dependent manner to the different emulsifiers, profound differences 
between emulsifiers were observed. Rhamnolipids, sophorolipids, and soy lecithin 
eliminated 91 ± 0, 89 ± 1, and 87 ± 1% of the viable bacterial population after 48 h, yet 
they all selectively increased the proportional abundance of putative pathogens. Moreover, 
profound shifts in butyrate (−96 ± 6, −73 ± 24, and −34 ± 25%) and propionate (+13 ± 24, 
+88 ± 50, and +29 ± 16%) production were observed for these emulsifiers. Phylogenetic 
prediction indicated higher motility, which was, however, not confirmed by increased 
flagellin levels using the TLR5 reporter cell assay. We conclude that dietary emulsifiers 
can severely impact the gut microbiota, and this seems to be proportional to their 
emulsifying strength, rather than emulsifier type or origin. As biotechnological emulsifiers 
were especially more impactful than chemical emulsifiers, caution is warranted when 
considering them as more natural alternatives for clean label strategies.
Keywords: dietary emulsifiers, human gut microbiota, interindividual variablility, microbiome composition, 
emulsifier origin, microbiome functionality
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INTRODUCTION
The current obesity crisis and related health conditions are 
increasingly associated with the overconsumption of so-called 
ultra-processed food products (Broussard and Devkota, 2016; 
Monteiro et  al., 2017; Rauber et  al., 2018; Waterlander et  al., 
2018; Branca et  al., 2019). Food additives are characteristic 
elements of said products (Monteiro et al., 2013, 2017; Carocho 
et  al., 2014) and are added to enhance, among others, shelf 
life, palatablility, texture, color, and nutritional value. However, 
the health impact of certain food additives has always been 
questioned (Payne et  al., 2012; Carocho et  al., 2014; Miclotte 
and Van de Wiele, 2019), and at this moment, the use of 
food additives in food products is one of the main public 
concerns about food in Europe (EFSA, 2019).
Diet is known to have a strong and fast impact on the gut 
microbiota (Musso et  al., 2010; Martínez Steele et  al., 2017; 
Ding et  al., 2019), which is generally considered an important 
parameter of gut and overall health (Musso et al., 2010; Bischoff, 
2011; Ding et  al., 2019). An unbalanced gut microbiota is 
being related to several physical and mental illnesses and 
conditions (Ding et  al., 2019). With respect to obesity and 
non-communicable diseases, a dysbiosed gut microbiota is 
characterized by a lower alpha diversity and is related to 
increased harvest from food and decreased fatty acid oxidation, 
glucose tolerance, production of satiety hormones, and intestinal 
barrier integrity (Musso et  al., 2010).
Recently, research has emerged that ties the consumption of 
additives to health markers through the gut microbiota. Dietary 
emulsifiers in particular have been proposed to display a destabilizing 
impact on gut health. Chassaing et  al. (2015, 2017) found 
in vivo that sodium carboxymethylcellulose (CMC) and polysorbate 
80 (P80) increase gut microbial motility and lower mucus layer 
thickness, yielding an increased production of pro-inflammatory 
compounds, low-grade gut inflammation, and weight gain. Another 
study has linked glycerol monolaurate (GML) with signatures of 
metabolic syndrome together with the alterations of gut microbiota 
composition, among which decreased abundance of Akkermansia 
muciniphila and increased abundance of Escherichia coli (Jiang 
et  al., 2018). The latter study is particularly relevant since GML 
is one of the World’s most widely used dietary emulsifiers (E471).
Knowledge that is currently still lacking from literature 
regarding the impact of dietary emulsifiers is what characteristics 
of an emulsifier determine its destabilizing effects, whether 
alternative, more natural emulsifiers could be  safer and to 
what extent the unique features of an individual’s microbiome 
play a role in the purported effects on the microbiome.
The present study describes the effects of five dietary emulsifiers: 
CMC, P80, soy lecithin, sophorolipids, and rhamnolipids (RLs). 
The first two, CMC and P80 are the synthetic emulsifiers that 
have been used for years and both are considered safe for human 
oral consumption. CMC is a water soluble anionic polymer 
with water-binding properties, due to which it is used as a 
thickener, emulsifier, or water-retainer in applications like 
pharmaceuticals, food products, paper, cosmetics, detergents, etc. 
(Hercules Inc., and Aqualon, 1999; Biswal and Singh, 2004). In 
Europe, CMC can be  used in many food products at quantum 
satis levels (European Commision, 2014), and in the United States, 
CMC carries the GRAS-status (generally recognized as safe) for 
the applications in food (FDA, 2019b, 2020). P80 is a member 
of the polysorbates, a group of non-ionic surfactants with 
applications mainly in the food, cosmetics, and pharmaceutical 
industries (Nielsen et  al., 2016; FMI, 2020). With an acceptable 
daily intake of 25  mg/kg BW/day (Aguilar et  al., 2015), EFSA 
allows its use in products like sauces, soups, chewing gum, 
coconut milk, dairy products, and usually at maximal 
concentrations of 10–10,000  mg/kg, depending on the product 
(European Commision, 2011). Also the United  States Food and 
Drug Administration (FDA) limits the use of P80 to 4–10,000 mg/
kg, depending on the product (FDA, 2019a).
Soy lecithin is a mixture of phospholipids (at least 60%), 
triglycerides, sterols, and carbohydrates obtained by extraction 
from soybeans. It is more widely used than CMC and P80, 
primarily in bakery products, ice creams, chocolate etc. 
(European Commision, 2018). Lecithins are allowed by EFSA 
in most food applications in quantum satis levels, and also 
the FDA considers soy lecithin a GRAS compound (Carocho 
et al., 2014; FDA, 2019c). Even though soy lecithin is considered 
safe or even beneficial for health (Ehehalt et  al., 2010; Mourad 
et  al., 2010; Stremmel et  al., 2010), the impact of soy lecithin 
on the gut microbiota has never been studied. Since this 
compound is one of the most extensively used food emulsifiers, 
it was incorporated in this research.
Finally, rhamnolipids and sophorolipids are two biotechnological 
emulsifiers of microbial origin. Due to their advantageous properties 
with respect to (eco) toxicity and waste stream reuse (Haba et al., 
2003; Van Bogaert et  al., 2011; Costa et  al., 2017), they are 
currently under consideration as novel food additives (Cameotra 
and Makkar, 2004; Costa et  al., 2017; Nitschke and Silva, 2018). 
Their strong emulsifying capacities (Van Bogaert et  al., 2011; 
Costa et  al., 2017) and more natural origin (biotechnological 
production from renewable resources) could qualify them as 
adequate alternatives for emulsifiers of chemical origin, which 
the food industry is currently seeking to replace under the umbrella 
of the “clean label” trend (Asioli et  al., 2017; Costa et  al., 2017; 
Nitschke and Silva, 2018). However, given their strong antimicrobial 
properties, an evaluation at the level of the gut microbiota is 
highly warranted before such applications can be  legalized.
Here, we investigated the effects of the five above-mentioned 
dietary emulsifiers on human fecal microbiota through 48  h 
in vitro batch incubations. This set of emulsifiers enables the 
comparison of the previously-studied chemical emulsifiers with 
the natural extract lecithin and with biosurfactants. In order 
to take into account interindividual variability in microbiome 
composition as a possible determinant of the putative impact 
from emulsifiers, we  separately assessed microbial incubations 
from 10 different individuals.
MATERIALS AND METHODS
Experimental Design
Fecal material from 10 human individuals was collected and 
separately incubated for 48  h with the five emulsifiers at three 
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concentrations [0.005, 0.05, and 0.5% (m/v)]. Emulsifier 
concentrations were chosen based on the maximal legal 
concentration in food products (EFSA and FDA), which comply 
with commonly applied concentrations in food products (Mallet, 
1992; Adams et al., 2004; Msagati, 2012). Each donor incubation 
series also included a control condition, in which a sham treatment 
with an equivalent volume of distilled water was performed.
The emulsifiers used during this study were sodium CMC, 
P80, soy lecithin, sophorolipids, and rhamnolipids. CMC (catalog 
number 419303: average molecular weight of 250,000  g/mol 
and degree of substitution of 0.9), P80 (P4780 – suitable for 
cell culture) and rhamnolipids (RLs: R90–90% pure) were 
obtained from Sigma Aldrich, St. Louis, MO, United  States. 
Soy lecithin was obtained from Barentz Unilecithin (UNILEC–
ISL non GMO IP), and sophorolipids were obtained from the 
UGent Inbio group from the Centre for Synthetic Biology. 
The latter were described as 75% (w/v) solutions, and their 
composition was determined to be mainly lactonic, diacetylated 
C18:1 SL.
Donors 2 and 6 reported to follow a vegetarian and vegan 
diet. All other donors consumed an omnivorous diet. The age 
of the four female and six male donors varied from 23 to 
53  years old. None of the donors received any antibiotic 
treatment in the 3 months prior to their donation. Experimental 
work with fecal microbiota from human origin was approved 
by the Ethical Committee of the Ghent University hospital 
under the registration number BE670201836318.
Batch Incubation
Before incubation, the five emulsifiers were supplemented to 
amber penicillin bottles containing 40 ml of autoclaved low-sugar 
nutritional medium (per L: 0.25  g gum arabic, 0.5  g pectin, 
0.25 g xylan, 1 g starch, 3 g yeast extract, 1 g proteose peptone, 
and 2  g pig gastric mucin; all from Sigma Aldrich, St. Louis, 
MO). The amounts of emulsifiers to add were calculated to 
obtain concentrations of 0.005, 0.05, and 0.5% (m/v) in a final 
volume of 50  ml (the volume obtained after addition of the 
fecal slurry). The bottles were stored in a 4°C fridge until use 
(for maximum 3  days).
At the start of the batch experiments, the penicillin flasks 
containing nutritional medium and emulsifiers were brought 
to room temperature to provide an ideal growth environment 
for the fecal bacteria. Fresh fecal samples were then collected 
in airtight plastic lidded containers. AnaeroGen™ sachets (Oxoid 
Ltd., Basingstoke, Hampshire, UK) were used to sequester O2. 
The samples were stored at 4°C until the use for a maximum 
of 3  h. A fecal inoculum was then prepared as described in 
De Boever et  al. (2000), by mixing 20% (w/v) fecal material 
into a 0.1 M anaerobic phosphate buffer (pH 6.8) supplemented 
with 1  g/L sodium thioglycanate as a reducing agent. Into 
each penicillin bottle, 10  ml of fecal inoculum was added, 
after which the bottles were closed with butyl rubber stoppers 
and aluminum caps. The headspaces were flushed with a 
N2/CO2 (80/20)-gas mixture using a gas exchange equipment 
to obtain anaerobic conditions and incubated in an IKA® KS 
4000 I  Control shaker at 200  rpm at 37°C. During the course 
of the experiments, the pH was followed up every day with 
a Prosense QP108X pH-electrode connected to a Consort C3020 
multi parameter analyzer to ensure stable and viable growth 
conditions (pH remained within 5.5–6.8).
Aliquots were taken on three timepoints: immediately after 
the start of the incubation (T0; 2–3  h after combining the 
fecal inoculum with the medium containing emulsifier), after 
24  h of incubation (T1) and after 48  h of incubation (T2). 
Samples were taken for short chain fatty acid (SCFA) analysis 
(1 ml), 16S rRNA gene amplicon sequencing (1 ml), for flagellin 
detection (500  μl), and for immediate fluorescent cell staining 
and flow cytometry (100 μl). SCFA-, flagellin-, and sequencing-
samples were stored at −20°C until analysis.
Intact/Damaged Cell Counts
To assess the impact of the emulsifiers on total and intact 
cell concentrations, cell staining with SYBR® green and propidium 
iodide was performed after which the cells were counted on 
an Accuri C6+ Flow cytometer from BD Biosciences Europe. 
The combination of these two cell stains is frequently used 
to distinguish intact bacterial cells from cells damaged at 
the level of the cell membrane, since SYBR® green enters 
any cell rapidly, while propidium iodide, being a larger 
molecule, enters intact cells much slower and mainly stains 
damaged cells within commonly applied incubation times 
(Van Nevel et  al., 2013). Samples were analyzed immediately 
after sampling to preserve the intact cell community. Dilutions 
up to 10−4 and 10−5 were prepared in 96-well plates using 
0.22  μm filtered 0.01  M phosphate buffered saline (PBS; 
HPO42−/H2PO4−, 0.0027  M KCl, and 0.137  M NaCl, pH 7.4, 
at 25°C), and these were subsequently stained with SYBR® 
green combined with propidium iodide (SGPI, 100× concentrate 
SYBR® Green I, Invitrogen, and 50× 20  mM propidium 
iodide, InvitroGen, in 0.22  μm-filtered dimethyl sulfoxide; 
Van Nevel et  al., 2013; Props et  al., 2016). After 25  min of 
incubation, the intact and damaged cell populations were 
measured immediately with the flow cytometer, which was 
equipped with four fluorescence detectors (530/30, 585/40, 
>670, and 675/25  nm), two scatter detectors and a 20  mW 
488  nm laser. The flow cytometer was operated with Milli-Q 
(Merck Millipore, Belgium) as sheath fluid. The blue laser 
(488  nm) was used for the excitation of the stains, and a 
minimum of 10,000 cells per sample were measured for 
accurate quantification. Settings used were an FLH-1 limit 
of 1,000, a measurement volume of 25 μl, and the measurement 
speed was set to “fast.” Cell counts were obtained by gating 
the intact and damaged cell populations in R (version 3.6.2) 
according to the Phenoflow-package (v1.1.6; Props et  al., 
2016). Gates were verified using data from negative 
control samples (only 0.22  μm filtered 0.01  M PBS; 
Figure S1 in Supplementary Data Sheet 1).
SCFA-Analysis
The SCFA-concentrations were determined by means of diethyl 
ether extraction and capillary gas chromatography coupled to 
a flame ionization detector as described by De Paepe et al. (2017)  
and Anderson et  al. (2017). Briefly, 1  ml aliquots were diluted 
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2× with 1  ml milli-Q water, and SCFA were extracted by 
adding approximately 400 mg NaCl, 0.5 ml concentrated H2SO4, 
400  μl of 2-methyl hexanoic acid internal standard and 2  ml 
of diethyl ether before mixing for 2  min in a rotator and 
centrifuging at 3,000  g for 3  min. Upper layers were collected 
and measured using a GC-2014 capillary gas chromatograph 
(Shimadzu, Hertogenbosch, Netherlands), equipped with a 
capillary fatty acid-free EC-1000 Econo-Cap column (Alltech, 
Lexington, KY, United States), 25 m × 0.53 mm; film thickness 
1.2  μm, and coupled to a flame ionization detector and split 
injector. One sample [donor 9, timepoint 2–0.05% (m/v) 
CMC] returned only zero values, presumably due to a technical 
error. This sample was therefore omitted prior to computational 
analyses.
Amplicon Sequencing
Samples from T0 and T2 were selected for Illumina 16S 
rRNA gene amplicon sequencing. The samples (1  ml) were 
first centrifuged for 5  min at 30,130  g in an Eppendorf 5430 
R centrifuge to obtain a cell pellet. After removing the 
supernatant, the pellets were subjected to DNA-extraction 
(Vilchez-Vargas et al., 2013; De Paepe et al., 2017). The pellets 
were dissolved in 1  ml Tris/HCl (100  mM, pH  =  8.0) 
supplemented with 100  mM EDTA, 100  mM NaCl, 1% (w/v) 
polyvinylpyrrolidone, and 2% (w/v) sodium dodecyl sulfate 
after which 200 mg glass beads (0.11 mm Sartorius, Gottingen, 
Germany) were added, and the cells were lysed for 5  min 
at 2,000 rpm in a FastPrep VR-96 instrument (MP Biomedicals, 
Santa Ana, CA). The beads were then precipitated by 
centrifugation for 5  min at 30,130  g, and the supernatant 
was collected. Purification of DNA took place by the extraction 
of cellular proteins with 500  μl phenol-chloroform-isoamilyc 
alcohol 25-24-1 at pH7 and 700  μl 100% chloroform. The 
DNA was precipitated by adding 1 volume of ice-cold isopropyl 
alcohol and 45  μl sodium acetate and cooling for at least 
1  h at −20°C. Isopropyl alcohol was then separated from 
DNA by centrifugation for 30  min at 4°C and at 30,130  g, 
and the pellet was dried by pouring off the supernatant. It 
was resuspended in 100 ml 1× TE buffer (10 mM Tris, 1 mM 
EDTA) for storage at −20°C.
DNA-quality was verified by electrophoresis in a 1.5% 
(w/v) agarose gel (Life technologies, Madrid, Spain), and 
DNA-concentration was determined using a QuantiFluor® 
dsDNA kit (detection limit: 50 pg/ml; sensitivity: 0.01–200 ng/
μl) and GloMax®-Multi+ system (Promega, Madison, WI) 
with the blue fluorescence optical kit installed (Ex: 490  nm 
and Em: 510–570  nm).
Library preparation and next generation 16S rRNA gene 
amplicon sequencing were performed at the VIB nucleomics core 
(VIB, Gasthuisberg Campus, Leuven, Belgium) as described in 
Tito et  al. (2017). The V4 region of the 16S rRNA gene was 
amplified using the bacterial 515F (GTGYCAGCMGCCGCGGTAA) 
and the 806R (GGACTACNVGGGTWTCTAAT) primers, which 
were modified with both Illumina adapters as well as adapters 
for directional sequencing. Sequencing was then performed on 
an Illumina MiSeq platform (Illumina, Hayward, CA, United States) 
according to manufacturer’s guidelines.
One sample [donor 3, timepoint 2, 0.05% (m/v) sophorolipids] 
failed to sequence. The sequencing data have been submitted 
to the National Center for Biotechnology Information (NCBI) 
database under the accession number PRJNA630547.
Processing of amplicon data was carried out using mothur 
software version 1.40.5 and guidelines (Kozich et  al., 2013). 
First, contigs were assembled, resulting in 14,977,727 sequences, 
and ambiguous base calls were removed. Sequences with a 
length of 291 or 292 nucleotides were then aligned to the 
silva_seed nr.123 database, trimmed between positions 11,895 
and 25,318 (Quast et al., 2013). After removing the sequences 
containing homopolymers longer than nine base pairs, 92% 
of the sequences were retained resulting in 2,957,626 unique 
sequences. A pre-clustering step was then performed, allowing 
only three differences between sequences clustered together 
and chimera. vsearch was used to remove chimeras, retaining 
79% of the sequences. The sequences were then classified 
using a naïve Bayesian classifier against the Ribosomal Database 
Project (RDP) 16S rRNA gene training set version 16, with 
a cut-off of 85% for the pseudobootstrap confidence score. 
Sequences that were classified as Archaea, Eukaryota, 
Chloroplasts, unknown, or Mitochondria at the kingdom level 
were removed. Finally, sequences were split at the order level 
into taxonomic groups using the OptiClust method with a 
cut-off of 0.03. The data were classified at a 3% dissimilarity 
level into OTUs resulting in a .shared (count table) and a 
.tax file (taxonomic classification).
For the entire dataset of 319 samples, 95,511 OTUs were 
detected in 175 genera. An OTU was in this manuscript defined 
as a collection of sequences with a length between 291 and 
292 nucleotides and with 97% or more similarity to each other 
in the V4 region of their 16S rRNA gene after applying 
hierarchical clustering.
Cell Culture for Flagellin Detection
Murine TLR5-expressing HEK 293 cells (InvivoGen), which 
are designed to respond to bacterial flagellin in cell culture 
medium, were cultured according to the manufacturer’s 
guidelines. Cells were grown from an in house created frozen 
stock in Dulbecco’s modified Eagle’s growth medium (DMEM; 
4.5  g/L glucose, 10% fetal bovine serum, 50  U/ml penicillin, 
50 μg/ml streptomycin, and 2  mM L-glutamine) supplemented 
with 100  μg/ml Normocin™ and maintained in culture in 
DMEM growth medium supplemented with 100  μg/ml 
Normocin™, 10 μg/ml of blasticidin, and 100 μg/ml of Zeocin™. 
Medium was refreshed every 2 days, and the cells were passaged 
when reaching 70–80% confluency.
Assays for flagellin detection were performed as instructed 
by InvivoGen, using cells from the passages 4–9. Samples from 
donors 3, 5, and 7 were selected for this assay based on a 
high, intermediate, and low metabolic responses to the emulsifiers, 
as measured by the SCFA-levels. Before combining with the 
HEK-blue cells, the samples were purified to obtain only the 
bacterial cells by first diluting them one-fourth in UltraPure™ 
DNase/RNase-Free distilled water (InvitroGen), then centrifuging 
twice at 4,226 g for 10 min, with a washing step using 0.22 μm 
filtered PBS in between. The resulting cell pellet was dissolved 
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into 0.22  μm filtered PBS. A standard curve (1.25–1.95  ng/ml), 
prepared from recombinant flagellin from Salmonella 
typhymurium (RecFLA-ST, InvivoGen) in sterile water was also 
added to the plate in triplicate. After an incubation for 23  h, 
absorbances were obtained using a Tecan Infinite F50 plate 
reader at 620  nm.
As a check for the viability of the cell culture after combination 
with the samples, a resazurin assay was performed. To this end, 
the supernatant from the cell culture plate used for the flagellin 
assay was discarded after the first incubation phase. The cells 
were then washed using 0.22 μm filtered PBS. For the detection 
part of the assay, three wells were spiked with 20 µl of a 5% 
Trition solution, as a positive control, while the rest of the wells 
received 20 µl PBS. Then, 180 µl of a 0.01 µg/ml resazurin 
solution was added to all wells. After 3  h of incubation at 37°C 
and 10% CO2, cell activity was measured using a Glomax®-
Multi1 system (Promega, Madison, WI) with filter the green 
fluorescence optical kit (Ex: 525  nm and Em: 580–640  nm).
Data Analysis and Statistics
Data visualization and processing was performed in R version 
3.4.2 (2017-09-28; R Core Team, 2016) and Excel 2016. All 
hypothesis testing was done based on a significance level of 
5% (α  =  0.05).
Cell Counts and SCFA
After loading the cell count table in R, total cell counts were 
calculated as the sum of the intact and damaged cell counts. 
The data were explored by calculating intact/damaged cell count 
ratio’s and percentages of intact cells at different timepoints. 
For plotting, both the 10,000× and 100,000× dilutions were 
taken into account. Boxplots of total and intact cell counts, 
as well as intact/damaged ratio’s were created using ggplot2 
(v3.2.1) in which the stat_compare_means function was used 
to check the significance of the emulsifier effect, by means of 
a Kruskal–Wallis test.
Statistical analysis of SCFA-levels was similar to that of the 
cell counts. Production levels of acetate, propionate, and butyrate 
over 48 h (CT2–CT0) were first calculated, and then the boxplots 
were created using ggplot2. Significance of the effect of the 
emulsifier treatment was tested with stat_compare_means using 
Wilcoxon Rank Sum tests with Holm’s correction and Kruskal–
Wallis test for overall group comparison.
Amplicon Sequencing Data
The shared and taxonomy files resulting from the mothur 
pipeline were loaded into R for further processing. Singletons 
(OTUs occurring only once over all samples) were removed, 
resulting in 36,496 OTUs being retained (McMurdie and Holmes, 
2014). Rarefaction curves were created to evaluate the sequencing 
depth (Figure S2 in Supplementary Data Sheet 1; Oksanen 
et  al., 2019). As the number of 16S rRNA gene copies present 
within bacteria differs between species, a copy number correction 
of the reads was carried out by first classifying the representative 
sequences of the OTUs (also obtained via the mothur pipeline) 
using the online RDP classifier tool, then obtaining both a 
copy number corrected read classification and a non-copy 
number corrected one, calculating the copy number by dividing 
both and finally dividing the acquired read counts in the shared 
file by the calculated copy numbers.
Both relative and absolute abundances of the OTUs and 
genera were calculated from the copy number corrected read 
counts and were explored via bar plots using ggplot2 (v3.2.1). 
Relative abundances were calculated as percentages of the total 
read counts per sample. Absolute abundances were calculated 
(quantitative microbial profiling) by multiplying the total cell 
counts obtained via flow cytometry with the relative abundances 
of the OTUs (similar to Vandeputte et  al., 2017).
Overall community composition was visualized using principle 
coordinate analysis (PcoA) on the abundance based Jaccard 
distance matrix using the cmdscale-function in the stats (v3.6.2) 
package. To investigate the effects of the individual constraints 
on the microbial community, a series of distance based 
redundancy analyses (dbRDAs) was then performed on the 
scores obtained in the PCoA on the Jaccard distance matrix 
using the capscale function in the vegan (v2.5.6) package. 
Permutation tests were used to evaluate the significance of 
the models and of the explanatory variables (De Paepe et  al., 
2018). The global model included the factors emulsifier, emulsifier 
concentration, timepoint, and donor as explanatory variables 
and the absolute abundances of the genera as explanatory 
variables. In a first dbRDA, this full model was included, to 
investigate the share of variance explained by each constraint 
variable. The timepoint factor was distinguished as the factor 
causing the largest share of variance, and since its effect was 
of little interest to us it was partialled out in further dbRDAs. 
To check for the effect of the donor variable on the microbial 
community, second and third dbRDAs were performed, with 
and without conditioning of the donor variable. The final model 
then visualized the effects of the treatments (defined by factors 
emulsifier and emulsifier concentration). The results of the 
dbRDAs were plotted as Type II scaling correlation triplots 
showing the two first constrained canonical axes (labeled as 
dbRDA Dim 1/2) and the proportional constrained eigenvalues 
representing their contribution to the total (both constrained 
and unconstrained) variance.
The Chao1, ACE-1, Shannon, Simpson, InvSimpson, and 
Pielou diversity indices were calculated for the microbial 
community after 48  h incubation based on the copy number 
corrected OTU-table using the SPECIES (v1.0) package and 
the diversity function in the vegan (v2.5.6) package. Indices 
were plotted using ggplot2, and significances were tested using 
pairwise Wilcoxon Rank Sum tests with Holm’s correction 
(ggpubr package v.0.2.4).
To evaluate differential abundance of genera between emulsifier 
treatments and control, the DESeq2 package (v 1.24.0) was 
applied on the copy number corrected count-table at genus 
level. In order to streamline the DESeq-analysis, pre-filtering 
according to McMurdie and Holmes (2014) was first applied 
on the copy number corrected count-table, after which a genus-
level table was created using the aggregate function (stats 
package v3.6.3). In the generalized linear model, the factor 
timepoint, donor, and treatment – a concatenation of the 
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emulsifiers and their concentrations – were included. A likelihood 
ratio test was employed within the DESeq function on the 
reduced model, containing only the factors donor and timepoint, 
to test for the significance of the model. Low count genera 
were subjected to an empirical Bayesian correction (Love et al., 
2014). For pairwise comparison of treatments versus controls, 
Wald tests were used after shrinkage of the Log2FoldChange 
(L2FC) values by means of the lfcShrink function. Values of 
p were adjusted by means of a Benjamini-Hochberg procedure 
(Love et  al., 2014). Results were visualized in volcanoplots, 
displaying the −log(adjusted p-value) versus the Log2FoldChange 
of each genus. Additionally, box plots were created showing 
the log-transformed pseudocounts extracted by the plotCounts 
function for each genus that showed significant differential 
abundance. Since for CMC and P80, no significantly altered 
genera were found, and these emulsifiers were omitted from 
the boxplots.
Finally, to summarize relations between the emulsifier 
treatments and the intact cell counts, the SCFA-data and the 
16S rRNA sequencing data, a partial redundancy analysis was 
carried out performed using the rda function in the vegan 
package (v2.5.6). The acetate, propionate, and butyrate 
concentrations, the intact cell counts and the relative abundance 
of the genera were set as response variables and the factors 
emulsifier, emulsifier concentration, donor, and timepoint as 
explanatory variables. Since the response variables carried 
different units, they were first centered on their mean using 
the scale function (base R v3.6.2). The factors donor and 
timepoint were partialled out to visualize solely the effect of 
the emulsifier treatments. The statistical significance of the 
effects was tested via a permutation tests, and the results were 
plotted in a Type II correlation triplot showing the first two 
constrained canonical axes (RDA1/2) annotated with their 
proportional eigenvalues representing their contribution to the 
constrained variance. The sites were calculated as weighed sums 
of the scores of the response variables.
Metagenome Prediction
Indications of functionality from phylogenetic information were 
obtained using PICRUSt (Phylogenetic Investigation of 
Communities by Reconstruction of Unobserved States; Langille 
et  al., 2013). An OTU-table was first generated against the 
Greengenes reference database (v13.8) using a closed ref 
OTU-picking strategy. The obtained OTU-table was then run 
through PICRUSt’s normalize_by_copy_number.py script 
(Langille et  al., 2013), which divides the abundance of each 
OTU by its inferred 16S copy number (the copy number is 
inferred from the closest genome representative for a 16S 
Greengenes reference sequence). The metagenome was then 
predicted using Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database (Kanehisa et al., 2012). The prediction provided 
an annotated table of predicted gene family counts for each 
sample, where gene families were grouped by KEGG orthology 
identifiers. Significantly different L2-level pathways across 
emulsifier concentration were visualized in boxplots using the 
ggplot2 package (v3.2.1). Kruskal–Wallis tests were performed 
for the overall comparison of emulsifier concentrations within 
L2-pathways for each emulsifier and Wilcoxon rank sum tests 
were used for pairwise comparison of emulsifier concentrations 
vs. control. Also relying on PICRUSt (Langille et  al., 2013), 
the BugBase tool (Ward et  al., 2017) was used to determine 
the relative degree of biofilm formation, oxygen utilization, 
pathogenic potential, oxidative stress tolerance, and Gram-stain 
of the bacteria in the samples.
Flagellin Concentration
Initial data processing was executed in Excel 2016. First, a 
four-parametric logistic model was fitted to the standard curve 
using the 4PL-Curve Calculator from aatbio.com (AAT Bioquest., 
2019). Given our observation that the emulsifiers decreased 
HEK cell activity, flagellin concentrations were normalized by 
use of absorbance values obtained from the resazurin assays; 
flagellin concentrations were divided by the ratio of the 
absorbance values from the samples over the average absorbance 
values for the standard curve of the same plate. Graphs were 
created using ggplot2. Since donors were observed separately 
and no replicate experiments per donor were performed, no 
statistical tests were performed for the flagellin data.
Donor Diversity Analysis
Next to the clustering of the donors in the dbRDA described 
above, we  sought to assess the degree of susceptibility of the 
10 donors to the effects of the emulsifiers, in an attempt to 
identify overall more or less susceptible individuals. Since 
literature describes no workflow for this purpose, we elaborated 
our own. Donors were ranked in terms of their susceptibility 
to the emulsifiers using several parameters: the 48 h production 
of the three most abundant SCFAs (acetate, propionate, and 
butyrate), the intact cell counts at T2, and the relative and 
absolute abundance of the most abundant OTU in the OTU-table, 
Escherichia/Shigella, at T2. These calculations were performed 
in Excel 2016.
First, to correct for the batch-effect, the control-values were 
subtracted from the treatment-values for each donor. Next, 
the corrected treatment values were summated for each donor, 
to obtain a single value that expressed the donor’s susceptibility, 
and these values were then used to rank the donors from 
least to most susceptible for every parameter, visualized in 
bar graphs. This workflow was followed for each parameter.
Comparison of Equivalent Emulsifier 
Concentrations
Due to their stronger emulsifying properties, rhamnolipids and 
sophorolipids could reportedly be used in lower concentrations 
in food products than conventional chemical emulsifiers (Nitschke 
and Silva, 2018). Therefore, we  sought to compare the effects 
of the chemical emulsifiers, CMC and P80, versus those of 
the biosurfactants, rhamnolipids, and sophorolipids, with regard 
to their impacts on the gut microbiota at equivalent emulsifying 
concentrations. Wilcoxon Rank Sum test was executed in R 
using the compare_means function on the same parameters 
we  used to evaluate donor diversity (see Donor Diversity 
Analysis section). As equivalent concentrations we  considered 
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a 10× lower concentration of biosurfactants compared to the 
chemical emulsifiers, given that this is what industry reports 
(Van Haesendonck and Vanzeveren, 2006). Hence, we compared 
the condition of 0.5% (m/v) of chemical emulsifiers with that 
of 0.05% (m/v) of biosurfactancs and 0.05% (m/v) of chemical 




Analysis of intact and damaged cell populations with flow 
cytometry (SGPI-staining defines damage at the level of the 
cell membrane; Falcioni et  al., 2008; Wlodkovic et  al., 2009; 
Buysschaert et  al., 2018), was used as a proxy for emulsifier 
toxicity. First, total and intact cell counts in the controls dropped 
by 14 ± 2 and 21 ± 3%, respectively, after 48 h in vitro incubation 
due to exhaustion of nutritional medium (Tables S1, 
S2 in Supplementary Data Sheet 1). When considering the 
impact of the emulsifiers, we observed that higher concentrations 
of rhamnolipids, sophorolipids, and soy lecithin resulted in 
significantly lower total and intact cell counts (Figures  1, 2 
and Table S3 in Supplementary Data Sheet 1). At 0.5% (m/v) 
rhamnolipids, intact cells decreased by 91  ±  0% after 48  h 
compared to the control sample of T0. At 0.5% (m/v) sophorolipids, 
about 89 ± 1%, was lost and at 0.5% (m/v) soy lecithin, 87 ± 1% 
was lost. The toxic effects were immediate for the sophorolipids 
and rhamnolipids, while for soy lecithin this decreasing effect 
only became significantly apparent after 24  h (T1; Figure  2). 
The impact of CMC and P80 toward the cell population was 
less pronounced. CMC even increased the total cell counts (not 
significantly) at higher concentrations, although the fraction of 
living cells remained unaffected for all CMC-conditions.
Microbial Community
The impact from the emulsifiers toward microbial community 
structure was assessed with 16S rRNA gene amplicon sequencing. 
First, the in vitro conditions had an impact on microbiota 
composition. While each donor showed a unique profile of 
microbial genera at the start of the experiment, more similar 
microbial community profiles were obtained upon incubation, 
primarily due to an increase in Escherichia/Shigella abundance 
from 0.02  ±  0.02 to 16  ±  25%, an increase in Bacteroides from 
21 ± 17 to 42 ± 20%, a decrease in Faecalibacterium from 21 ± 16 
to 1  ±  1% and a decrease in Prevotella from 13  ±  23 to 2  ±  4% 
(Figures S3–S5 in Supplementary Data Sheet 1). These alterations 
can be  attributed to the feed composition, in which the relative 
enrichment in protein as well as the low carbohydrate 
concentration may have favored the growth of protein loving 
FIGURE 1 | Type II scaling triplot obtained using partial redundancy analysis of the microbial community detected after 48 h of in vitro batch incubations of  
fecal material from 10 human donors in sugar depleted medium supplemented with five emulsifiers at four concentrations. In the main figure, the intact cell  
count, the short chain fatty acid (SCFA)-levels, and the relative abundance of the top two genera are shown as response variables (red arrows), and emulsifier 
concentration are given as explanatory variables (blue arrows). The top right figure also displays the samples as sites. Axes are annotated with their contribution to 
the total variance.
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Escherichia/Shigella and versatile Bacteroides species over the more 
specialized and carbohydrate-loving Prevotella and Faecalibaterium 
species (Mu et  al., 2016; Yao et  al., 2016; Diether and Willing, 
2019; Verhoog et  al., 2019).
Independent from the in vitro effects, clear differences 
were noted between emulsifier treatments and controls, which 
were both emulsifier‐ and donor-dependent (Figure  3 and 
Figures S4, S5 in Supplementary Data Sheet 1). Where the 
A
B
FIGURE 2 | Average total (A) and intact (B) bacterial cell counts (cells/ml) detected during in vitro batch incubations of fecal material from 10 donors with sugar 
depleted medium supplemented with five emulsifiers at four concentrations. Samples were taken upon incubation (T0; 2-3 h after inoculation) as well as after 24 h 
(T1) and 48 h (T2) of incubation. Asterisks indicate significant differences detected with a Kruskal–Wallis test (α = 0.05).
A B
FIGURE 3 | Type II scaling triplots obtained using partial distance based redundancy analysis of the microbial community composition detected using 16S rRNA 
gene amplicon sequencing after 48 h of in vitro batch incubations of fecal material from 10 donors with sugar depleted medium supplemented with five emulsifiers 
at four concentrations. Samples were taken upon incubation (T0; 2–3 h after inoculation) as well as after 24 h (T1) and 48 h (T2) of incubation. Factors donor, 
emulsifier, and emulsifier concentration were set as explanatory variables (blue arrows) and absolute abundances of genera as response variables (red arrows). Only 
the top five genera were displayed for adequate visibility. Axes are annotated with their contribution to the total variance. (A) The factor timepoint was partialled out. 
(B) The factors donor and timepoint were partialled out.
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effects of rhamnolipids and sophorolipids were most outspoken, 
the impact of soy lecithin was intermediary, and CMC and 
P80 had the smallest impacts (Figure  1). This was evidenced 
by significant drops in diversity indices upon incubation with 
rhamnolipids, sophorolipids and to a lesser extent soy lecithin 
(Figure  4). DESeq-analysis further revealed significant 
differential relative abundance of 36 genera, from which 23 
were increased and 13 were suppressed, compared to the 
control condition (Figures  5, 6). Rhamnolipids triggered the 
strongest changes, with the three most increased genera being 
unclassified Enterobacteriaceae (L2FC  =  3.85; padj  <  0.0001), 
Fusobacterium (L2FC  =  2.75; padj  <  0.0001), and 
Escherichia/Shigella (L2FC  =  2.49; padj  <  0.0001) and the 
three most suppressed ones being unclassified Bacteroidetes 
(L2FC = −2.19; padj = <6,323E-4), Barnesiella (L2FC = −2.09; 
padj  <  0.009), and Bacteroides (L2FC  =  −2.02; padj  <  0.002). 
The top three most increased genera for sophorolipids were 
Escherichia/Shigella (L2FC  =  1.86; padj  <  0.043), 
Acidaminococcus (L2FC  =  1.80; padj  <  0.0001), and 
Phascolarctobacterium (L2FC  =  1.68; padj  =  <0.0001) and the 
three most decreased were unclassified Bacteroidetes 
(L2FC  =  −1.97; padj  <  0.0001), Barnesiella (L2FC  =  −1.70; 
padj = <0.0001), and Bacteroides (L2FC = −1.53; padj = 3.034E-
06). The top three most increased genera by soy lecithin were 
Acidaminococcus (L2FC  =  1.23; padj  =  0.016), 
Porphyromonadaceae_unclassified (L2FC  =  1.19; padj  =  0.017), 
and Sutterella (L2FC  =  1.19; padj  =  0.004). Two significantly 
decreased genera were Flavonifractor (L2FC  =  −1.04; 
padj  =  0.009) and Pseudoflavonifractor (L2FC  =  −0.95; 
padj  =  0.015; Figures  5, 6).
Functional Analysis
Short Chain Fatty Acid
Short chain fatty acids were analyzed to study how exposure 
to dietary emulsifiers affects the general microbial metabolic 
activity. We  observed that SCFA-production was significantly 
FIGURE 4 | Diversity parameters of gut microbial community obtained after 48 h of in vitro batch incubations of fecal material from 10 donors with sugar depleted 
medium supplemented with five emulsifiers at four concentrations. Samples were taken upon incubation (T0; 2–3 h after inoculation) as well as after 24 h (T1) and 
48 h (T2) of incubation. Asterisks represent significant differences with control based on Wilcoxon Rank Sum tests with Holm’s correction (α = 0.05).
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and differently affected by rhamnolipids, sophorolipids, and 
soy lecithin, while no changes were observed for P80 and 
CMC (Figures  1, 7). The strongest impacts were noted for 
rhamnolipids, which, at 0.5% (m/v), significantly decreased 
total SCFA production by about 36  ±  5% (pWilcox  <  0.0001) 
compared to the control condition. This decrease was mainly 
attributed to a 32  ±  7% decrease in acetate production 
(pWilcox  <  0.0001) compared to the control. Rhamnolipids at 
0.5% (m/v) also reduced butyrate production by 96  ±  6% 
compared to the control condition (pWilcox  <  0.0001) while 
propionate production remained unaffected. Interestingly, 
incubation with 0.5% (m/v) sophorolipids also resulted in a 
decrease in butyrate production by 73  ±  24% compared to 
the control (pWilcox  <  0.0001), while propionate production 
increased by 88  ±  50% (pWilcox  =  2.1e-04). Soy lecithin at 0.5% 
(m/v) significantly increased propionate production by 29 ± 18% 
on average (pWilcox = 0.0089) and decreased butyrate production 
non-significantly by 34  ±  25% on average (pWilcox  =  0.035). No 
profound shifts in microbial fermentation activity were observed 
for incubations with CMC and P80.
Metagenomic Prediction
Other emulsifier related functional shifts were explored via 
metagenomic prediction using PICRUSt. These analyses 
predicted suppressing effects of rhamnolipids, sophorolipids 
on the pathways “Biosynthesis of other secondary metabolites,” 
FIGURE 5 | Volcano plots indicating gut microbial community alterations after 48 h of in vitro batch incubations of fecal material from 10 donors with sugar 
depleted medium supplemented with five emulsifiers at four concentrations. Samples were taken upon incubation (T0; 2–3 h after inoculation) as well as after 24 h 
(T1) and 48 h (T2) of incubation. Log2FoldChange (L2FC) of genus abundances for all emulsifier treatments vs. the control are presented on the x-axis and the log 
transformed adjusted p-value is presented on the y-axis. Significantly increased or decreased genera are indicated in respectively green and red. The dashed line 
represents the significance threshold of α = 0.05.
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“Cell growth and death,” and “Signalling molecules and 
interaction” (Figure S6 in Supplementary Data Sheet 1). 
Possible significantly upregulated level 2 pathways were “Cell 
motility,” “Cellular Processes and signaling,” “Genetic 
information processing,” “Lipid metabolism,” “Membrane 
transport,” “Metabolism,” “Signal transduction,” “Transcription,” 
and “Xenobiotics degradation.”
Plugging the data into the Bugbase-webtool revealed a 
significantly stimulating effect of sophorolipids and rhamnolipids 
on the formation of biofilms and mobile elements, stress 
tolerance and increased abundance of potential pathogens, 
Gram negative and facultative anaerobic bacteria all properties 
related to the Proteobacteria phylum. This coincides with our 
observation of an increased abundance of Escherichia/Shigella 
(Supplementary Data Sheet 2).
Flagellin Levels
In order to validate the PICRUSt prediction of a higher 
motility potential, a HEK-blue mTLR5 reporter cell assay 
was used for the detection of bacterial flagellin. The response 
of the flagellin concentrations to the emulsifiers was found 
to be  largely donor-dependent, and inconsistent shifts were 
observed in function of incubation time (Figure  8). Shifts 
in flagellin levels upon emulsifier dosage were variable, 
meaning that the prediction of higher motility by PICRUSt 
could not be  substantiated.
Donor Diversity
For all endpoints, inter-individual variability was observed in 
response to the in vitro incubations and emulsifier treatments 
(Figures S4, S5, S7 in Supplementary Data Sheet 1). In terms 
of community structure, Figure 3A shows that each donor clusters 
separately. This clustering was found to be significant (pdbRDA < 0.05).
To assess in more detail whether there was coherence in 
the read-outs with respect to donor susceptibility, we  ranked 
the donors according to their response on the most relevant 
parameters, i.e., intact cell counts, production of the most 
important SCFA (acetate, propionate, and butyrate), and the 
absolute and relative abundance of Escherichia/Shigella.
We observed that the susceptibility of the donors to the 
effects of the emulsifiers depended on the targeted parameter 
(Figure  9). Some donors consistently ranked as highly 
FIGURE 6 | Copy number corrected counts of significantly increased or decreased genera, obtained from DESeq analysis in R (version 3.4.2), after 48 h of 
exposure of gut microbial communities from 10 donors to soy lecithin, sophorolipids, and rhamnolipids during in vitro batch incubations. Asterisks represent 
significant differences with the control based on Wald tests (α = 0.05).
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susceptible (D9) or less susceptible (D6 and D1), while for 
other donors, ranking was more variable over the different 
parameters.
Equivalent Emulsifier Concentrations
We sought to compare the effects of biosurfactants versus those 
of conventional chemical emulsifiers. When comparing 0.5% 
(m/v) of chemical emulsifier with 0.05% (m/v) of biosurfactant 
– the concentrations most representative of the currently applied 
levels of dietary emulsifiers – the previously described effects 
of the biosurfactants (decreased levels of acetate, butyrate, 
intact and total cell concentration, and increased abundance of 
propionate and increased abundance of Escherichia/Shigella) were 
significant compared to the effects of the chemical emulsifiers 
(Table S4 in Supplementary Data Sheet 1). When comparing 
0.05% (m/v) of chemical emulsifier with 0.005% (m/v) of 
biosurfactant, the effects were not significantly different, except 
for the effects of rhamnolipids on the cell count data.
DISCUSSION
We found dietary emulsifiers to significantly alter human gut 
microbiota toward a composition and functionality with potentially 
higher pro-inflammatory properties. While donor-dependent 
differences in microbiota response were observed, our in vitro 
experimental setup showed these effects to be primarily emulsifier-
dependent. Rhamnolipids and sophorolipids had the strongest 
impact with a sharp decrease in intact cell counts, an increased 
abundance in potentially pathogenic genera-like Escherichia/Shigella 
and Fusobacterium, a decreased abundance of beneficial 
Bacteroidetes and Barnesiella, and a predicted increase in flagellar 
assembly and general motility. The latter was not substantiated 
through direct measurements, though. The effects were less 
pronounced for soy lecithin, while chemical emulsifiers P80 and 
CMC showed the smallest effects. Short chain fatty acid production, 
with butyrate production, in particular, was also affected by 
the respective emulsifiers, again in an emulsifier‐ and donor-
dependent manner.
One of the most profound impacts of emulsifier treatment 
toward gut microbiota was the decline in intact microbial 
cell counts. The degree of microbiome elimination in this 
study seems comparable to what has been observed for 
antibiotic treatments (Francino, 2016; Guirro et  al., 2019). 
Since antibiotics are considered detrimental for gut ecology, 
this may serve as a warning sign with respect to emulsifier 
usage. Emulsifiers also act as surfactants, which are known 
for their membrane solubilizing properties (Jones, 1999). The 
fact that the observed decline in microbial viability was 
dependent on emulsifier dose and on the emulsifying potential 
FIGURE 7 | Short chain fatty acid production levels over 48 h of incubation of fecal material from 10 donors in sugar depleted medium supplemented with five 
emulsifiers at four concentrations. Samples were taken upon incubation (T0; 2–3 h after inoculation) as well as after 24 h (T1) and 48 h (T2) of incubation. Asterisks 
indicate significant differences with the control [0% (m/v)], calculated with Wilcoxon Rank Sum tests with Holm’s correction. p-values indicate results of general 
Kruskal–Wallis tests (α = 0.05).
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of the supplemented compound, as measured by the aqueous 
surface tension reduction (Table  1), leads us to conclude 
that the dietary emulsifiers attack the bacterial cells principally 
at the level of the cell membrane.
We also found this antimicrobial effect from the tested 
emulsifiers to be  highly selective, confirming previous 
observations by Moore (1997) who showed that the effects of 
surfactants are dependent on the bacterial species. We  found 
the Escherichia/Shigella genus to be particularly resistant against 
the surfactants antimicrobial effects. This agrees with Kramer 
et  al. (1984) and Nickerson and Aspedon (1992) who 
demonstrated the surfactant resistance of enteric bacteria 
Enterobacter cloacae and E. coli against sodium dodecyl sulfate. 
They showed that this resistance is widespread among 
Enterobacteriaceae, that it is energy-dependent, and that exposure 
to sodium dodecyl sulfate altered the expressions of 19 proteins, 
of which three were later tentatively identified as clpP, clpB, 
and clpX intracellular proteases (Rajagopal et  al., 2002). Also 
membrane-derived oligosaccharides, present in the periplasm 
of Gram negative bacteria, were found to be  essential to the 
detergent-resistant properties of E. coli (Rajagopal et  al., 2003). 
Even though this could explain the increased abundance in 
this study for Enterobacteriaceae and Escherichia/Shigella, the 
mechanism by which other species are (un)affected by the 
emulsifiers is not known.
Interestingly, our prediction of altered functionality using 
PICRUSt analysis indicated a potential increase in levels of 
motility-genes, even though we  could not confirm increased 
flagellin levels by direct measurement. Increased motility has 
been observed upon addition of emulsifiers before (Lock et al., 
2018). This finding may again be  related to the increased 
relative abundance of Escherichia/Shigella, since these are known 
flagella (gene)-bearers (Girón, 1995; Tominaga et  al., 2001; 
Mittal et al., 2003). Increased flagellin levels constitute a potential 
health risk as flagellin is considered an important virulence 
factor; this particular microbe-associated molecular pattern may 
trigger inflammation upon binding to TLR5. A higher degree 
of flagellation would thus represent more motile bacteria and 
result in a gut microbiome that is able to more aggressively 
penetrate the mucus layer and subsequently reach gut epithelial 
cells (Ramos et  al., 2004; Chassaing et  al., 2015). Chassaing 
et  al. (2015, 2017) demonstrated possible consequences for the 
host: an increased inflammatory response in both gut and 
body, contributing to increased adiposity and weight gain.
Effects toward microbial metabolic functionality, as measured 
by SCFA-levels, were emulsifier-dependent. Nevertheless, 
consistent shifts in SCFA-profiles were observed for all three 
emulsifiers for which significant alterations were visible, i.e., 
a decrease in butyrate and an increase in propionate production. 
For sophorolipids, the strong increase in propionate 
production can be  related to the increased abundance of 
Phascolarctobacterium. This genus is known to produce 
propionate from succinate produced by E. coli cells (Del Dot 
et  al., 1993). For rhamnolipids, we  assume that similar cross-
feeding interactions occurred, even though propionate levels 
remained stable. We hypothesized that an increased propionate 
production by the Escherichia/Phascolarctobacterium consortium 
is counteracted by the higher antimicrobial activities from 
the rhamnolipids at increasing concentrations. The fact that 
L-rhamnose is a well-known propionate precursor (Reichardt 
et al., 2014), and that rhamnolytic pathways have been observed 
in E. coli and other Gammaproteobacteria (Rodionova et  al., 
2013) further support this idea. The increase in acetate and 
propionate production observed with soy lecithin can be linked 
to the metabolism of glycerol (De Weirdt et  al., 2010). This 
is in agreement with the upregulated abundances of the 
Enterococcus and Clostridium genera at higher levels of soy 
lecithin, since these genera are known to metabolize glycerol 
(Bradbeer, 1965; Bizzini et  al., 2010) as well as choline 
(Martínez-del Campo et al., 2015). Also the increased abundance 
of the Acidaminoccus genus would correspond with the increased 
acetate production (Chang et al., 2010). These findings indicate 
that observed shifts in SCFA-production can be  attributed 
to shifts in microbial composition.
Whether the altered SCFA-production and -levels are 
positive or negative for host health is ambiguous. On 
the one hand, decreased butyrate levels can be  considered 
negative, since butyrate is known to protect the gut 
epithelium from inflammation and cancerous growth (Canani 
et  al., 2011; Cani, 2017; Liu et  al., 2018). On the other 
hand, propionate is also considered a health-promoting SCFA 
(Hosseini et al., 2011; Weitkunat et al., 2016; Louis and Flint, 2017). 
FIGURE 8 | Flagellin concentrations obtained using mTLR5 HEK blue 
reporter cells for three donors at the start (T0) and the end (T2) of in vitro 48 h 
batch experiments of fecal material from 10 donors in sugar depleted medium 
supplemented with five emulsifiers at four concentrations. Donors for the 
flagellin assay were selected based on their low (D3), high (D7), and 
intermediate (D5) metabolic responses to the emulsifiers.
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Propionate production is related to decreased lipogenesis in 
the liver and is supposed to enhance satiety mechanisms, which 
would lower the chance of developing obesity (Hosseini et  al., 
2011; Weitkunat et  al., 2016). It is, however, questionable 
whether such benefit may predominate the purported negative 
effects from the observed antimicrobial effects and the increase 
in pro-inflammatory markers, such as flagellated microbiota 
and a drop in butyrate production.
Another point relating to health effects entails that 
rhamnolipids, sophorolipids, and – to a lesser extent – soy 
lecithin significantly decreased diversity parameters. Decreased 
microbiome diversity frequently occurs with compromised 
health conditions such as obesity, insulin resistance, 
dyslipidemia (Turnbaugh et  al., 2009; Le Chatelier et  al., 
2013), Type 1 diabetes (Patterson et  al., 2016), heart failure 
(Luedde et  al., 2017), and inflammatory bowel disease 
(Arumugam et al., 2011; Chassaing et al., 2015). The increased 
prevalence of the Escherichia/Shigella genus has also been 
observed with multiple metabolic conditions (Lupp et  al., 
2007; Lecomte et  al., 2015; Shin et  al., 2015). Increased 
Enterobacteriaceae abundance was previously linked with an 
increased gut permeability (Pedersen et  al., 2018), the 
consumption of high fat diets (Fei and Zhao, 2013;  
Lecomte et  al., 2015; He et  al., 2018), colitis (Lupp et  al., 
2007), cardiovascular disease (Jie et  al., 2017), diabetes 
(Allin et  al., 2015; Deschasaux et  al., 2019), and even 
undernourishment and iron deficiency anemia (Shin et al., 2015;  
Muleviciene et  al., 2018). With respect to soy lecithin, 
metabolism of phosphatidylcholine by the gut microbiota 
has been linked to cardiovascular disease (Wang et  al., 2011; 
Tang and Hazen, 2014). We also found an increased abundance 
of the genus Sutterella, a bacterium that has been linked to 
autism spectrum disorders (Wang et  al., 2013) and gut 
inflammation, notably by IgA-degradation (Moon et al., 2015; 
Kaakoush, 2020). Overall, we can, thus, conclude that exposure 
of the gut microbiota to dietary emulsifiers may result in 
profound compositional shifts, previously related to adverse 
health outcomes.
An important consideration is whether the observed in vitro 
effects would also take place in an in vivo setting. This will 
depend on a number of diet‐ and host-related factors. First, 
we  found that the observed effects were concentration‐ and 
emulsifier-dependent. Choosing an emulsifier-concentration 
combination that minimizes adverse microbial impacts, without 
compromising food technical properties, could thus be a strategy 
to mitigate the harmful effects of food emulsifiers. Second, 
emulsifier concentration will continuously alter during 
gastrointestinal digestion, but the impact of the dilution with 
accompanying food products, excretion of digestive fluids, or 
absorption of water from the gut lumen on the final concentration 
reaching the gut microbiota has so far not yet been studied. 
Third, digestion by human enzymes will alter chemical structure 
of the emulsifiers. While CMC is resistant to breakdown by 
human digestive enzymes (Joint FAO/WHO Expert Committee 
FIGURE 9 | Ranking of donors of fecal material for 48 h batch incubations in sugar depleted medium supplemented with five emulsifiers at four concentrations. 
Donors were ranked along the principal parameters impacted by the emulsifiers. Measures were calculated based on cumulative (sum of all treatments) change in 
48 h production of SCFA or cumulative 48 h change in living cell counts, relative or absolute abundances of Escherichia/Shigella.
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on Food Additives, 1973), P80 and soy lecithin can be hydrolyzed 
by pancreatic lipases. For P80, only the polyethylene-sorbitan 
unit may reach the colon (Aguilar et  al., 2015). Soy lecithin 
is mostly absorbed as lysolecithin and free fatty acids, but its 
detection in faces indicates that some fraction reaches the colon 
(Mortensen et al., 2017), where the choline and glycerol moieties 
are metabolized by the gut microbiota (Tang and Hazen, 2014). 
For both of these compounds, it will thus be  necessary to 
verify if and to what extent the observed effects occur in vivo 
as well. With respect to rhamnolipids and sophorolipids, no 
literature is currently available on their digestion by human 
enzymes. Preliminary data from our side, however, have indicated 
only one alteration, a deacetylation of the sophorose units of 
the sophorolipids (Supplementary Data Sheet 3). These 
compounds may thus readily reach the colon and interact with 
the endogenous microbiota. Fourth, other dietary constituents 
in the gut, primarily lipids, and bile salts, will interact with 
emulsifiers (Naso et  al., 2019). The mucus layer overlying the 
gut epithelium and the pH-fluctuations throughout the gut 
are other elements that may affect emulsifier-microbiota 
interactions. Finally, the total levels of emulsifiers consumed 
by an individual will determine both acute and chronic effects.
A last important element in the putative health impact 
from dietary emulsifiers concern’s interindividual variability. 
An individual’s unique microbiota and metabolism are 
important determinants of the potential health effects dietary 
emulsifiers could cause. While the overall effects from the 
different emulsifiers toward microbiota composition and 
functionality were quite consistent in our study, important 
interindividual differences in susceptibility of the microbiota 
were noted. Understanding what underlying factors and 
determinants drive this interindividual variability will be crucial 
to future health risk assessment of novel and existing 
dietary emulsifiers.
Food additives have come under scrutiny with respect to 
their impact on human health. Additives like colorants, artificial 
sweeteners, nitrites (NaNO2), and high fructose corn syrup 
have been associated with hyperactivity, cancer development, 
gastric cancer, and obesity, respectively (Arnold et  al., 2012; 
Bryan et  al., 2012; Payne et  al., 2012; Carocho et  al., 2014). 
TABLE 1 | Emulsifier characteristics of sodium carboxymethylcellulose, Span60, P80, phosphatidylcholine (major component of soy lecithin), sophorolipids, and 
rhamnolipids.
MW (g/mol) CMC* (mg/L) Source Min. S.T.** (mN/m) Source
Carboxymethylcellulose 250,0001,2 - -
Sorbitan tristearate 
(Span60)


















Zhang et al., 2017
Zhang et al., 2017
Wu and Wang, 2003
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Wu and Wang, 2003
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In answer to these public concerns, a clean label movement 
has developed in the food industry that aims to provide food 
products with a more natural image. In this light, we investigated 
whether rhamnolipids and sophorolipids, two biotechnological 
emulsifiers, would yield less of an impact on the gut microbiota 
than the mainstream chemical emulsifiers, CMC and P80. Our 
results showed however, that rhamnolipids and sophorolipids, 
of all emulsifiers in this study, had the strongest impact on 
microbiota composition and functionality, even when equivalent 
concentrations were taken into account. Further analysis of 
our data showed that the observed effects toward the microbiota 
can potentially be  linked to their higher emulsifying potential. 
All of this indicates that rhamnolipids and sophorolipids are 
probably no appropriate alternatives to conventional emulsifiers 
unless they are used at substantially lower concentrations. 
We  note, however, that the model used in this study has 
impacted the microbiota as well. More research must thus 
point out whether the effects prevail in different models, as 
wel as in vivo and if so, whether concentrations can be  kept 
low enough to avoid alleged adverse health effects.
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